Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors

PLoS One. 2013 May 16;8(5):e63744. doi: 10.1371/journal.pone.0063744. Print 2013.

Abstract

Background: HIV-infected controllers control viral replication and maintain normal CD4+ T cell counts. Long Term Non-Progressors (LTNP) also maintain normal CD4+ T cell counts, but have on-going viral replication. We hypothesized that different immunological mechanisms are responsible for preserved CD4+ T cell counts in controllers and LTNP.

Methods: 25 HIV-infected controllers and 14 LTNP were included in this cross-sectional study. For comparison, 25 progressors and 34 healthy controls were included. Production and destruction of T cells were addressed by determination of T cell receptor excision circles (TREC), recent thymic emigrants, naïve cells, immune activation, senescence and apoptosis. Furthermore, telomere length was determined, and the amount of lymphoid tissue in tonsil biopsies was quantified.

Results: Controllers presented with partly preserved thymic output, preserved expression of the IL-7 receptor and IL-7 receptor density, and lower levels of destruction of cells than progressors resembling HIV-negative healthy controls. In contrast, LTNP appeared much like progressors, and different from controllers in immune activation, senescence, and apoptosis. Interestingly, CD8+ RTE, TREC and telomere length were partly preserved. Finally, both controllers and LTNP displayed decreased amounts of lymphoid tissue compared to healthy controls.

Conclusions: Controllers presented with an immunological profile different from LTNP. While controllers resembled healthy controls, LTNP were similar to progressors, suggesting different immunological mechanisms to be responsible for preserved CD4+ T cell counts in LTNP and controllers. However, both controllers and LTNP presented with reduced amounts of lymphoid tissue despite preserved CD4+ T cell counts, indicating HIV to cause damage even in non-progressors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Cross-Sectional Studies
  • Female
  • Flow Cytometry
  • HIV Infections / genetics
  • HIV Infections / immunology*
  • HIV Seropositivity
  • Humans
  • Lymphoid Tissue / immunology
  • Lymphoid Tissue / metabolism
  • Male
  • Middle Aged
  • Receptors, Interleukin-7 / genetics
  • Receptors, Interleukin-7 / immunology
  • Telomere / genetics
  • Viral Load

Substances

  • Receptors, Interleukin-7

Grants and funding

This work was supported by University of Copenhagen, Novo Nordisk Foundation, Augustinus Foundation and Danish Medical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.